Drug Shortage Report for PMS-TADALAFIL

Last updated on 2018-09-19 History
Report ID 59128
Drug Identification Number 02409445
Brand name PMS-TADALAFIL
Common or Proper name TADALAFIL
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-09-25
Actual start date
Estimated end date 2019-02-10
Actual end date 2018-09-24
Shortage status Avoided shortage
Updated date 2018-09-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-09-19 French Compare
v3 2018-09-19 English Compare
v2 2018-08-24 French Compare
v1 2018-08-24 English Compare

Showing 1 to 4 of 4